Luisa Angileri
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Letter: Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: June 05, 2025
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis).
Journal: Archives of dermatological research
Published: February 27, 2025
Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab?
Journal: Journal of clinical medicine
Published: February 17, 2024
Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 10, 2023
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?
Journal: International clinical psychopharmacology
Published: October 02, 2023
Peristomal Skin Complications: Detailed Analysis of a Web-Based Survey and Predictive Risk Factors.
Journal: Healthcare (Basel, Switzerland)
Published: April 04, 2023
Topical tacrolimus during systemic therapy for severe atopic dermatitis in the clinical practice.
Journal: European review for medical and pharmacological sciences
Published: April 20, 2022
Effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: a preliminary report of real-world data.
Journal: Italian journal of dermatology and venereology
Published: April 08, 2022
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease.
Journal: The Journal of dermatological treatment
Published: March 09, 2022
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.
Journal: Clinical and molecular allergy : CMA
Published: October 04, 2021
Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis.
Journal: Acta dermato-venereologica
Published: September 14, 2021
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis.
Journal: Therapeutic advances in chronic disease
Published: July 12, 2021
Last Updated: 09/26/2026